KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Depreciation & Amortization - TotalEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Non-Controlling InterestsInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

National Health Investors (NHI) EBT (2016 - 2019)

National Health Investors filings provide 11 years of EBT readings, the most recent being $28.1 million for Q3 2019.

  • On a quarterly basis, EBT fell 1.79% to $28.1 million in Q3 2019 year-over-year; TTM through Sep 2019 was $105.1 million, a 4.13% decrease, with the full-year FY2019 number at $161.3 million, up 4.0% from a year prior.
  • EBT hit $28.1 million in Q3 2019 for National Health Investors, up from $26.2 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $35.0 million in Q4 2016 to a low of $18.6 million in Q2 2016.
  • Median EBT over the past 5 years was $28.1 million (2019), compared with a mean of $28.3 million.
  • Biggest five-year swings in EBT: crashed 41.34% in 2016 and later skyrocketed 43.06% in 2017.
  • National Health Investors' EBT stood at $31.9 million in 2015, then grew by 9.69% to $35.0 million in 2016, then fell by 20.48% to $27.8 million in 2017, then grew by 2.74% to $28.6 million in 2018, then dropped by 1.79% to $28.1 million in 2019.
  • The last three reported values for EBT were $28.1 million (Q3 2019), $26.2 million (Q2 2019), and $22.2 million (Q1 2019) per Business Quant data.